Co-Authors
This is a "connection" page, showing publications co-authored by Peter A. Serrano and Maria Figueiredo-Pereira.
Connection Strength
3.183
-
Figueiredo-Pereira ME, Rockwell P, Schmidt-Glenewinkel T, Serrano P. Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Front Mol Neurosci. 2014; 7:104.
Score: 0.453
-
Pattanashetty SG, Serrano PA, Rockwell P, Xie L, Figueiredo-Pereira ME. Terazosin drives sex-dependent adrenergic-bioenergetic reprogramming to restore network function in Alzheimer's disease. bioRxiv. 2026 Apr 06.
Score: 0.247
-
Terry GA, Aziz S, Raihana N, Xie L, Rockwell P, Serrano P, Figueiredo-Pereira ME. Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer's models. bioRxiv. 2026 Jan 21.
Score: 0.243
-
Birnbaum EM, Xie L, Serrano P, Rockwell P, Figueiredo-Pereira ME. BT-11 targets the LANCL2 pathway to attenuate cognitive deficits and hippocampal pathology in Alzheimer's transgenic rats. Sci Rep. 2025 Dec 23; 16(1):1848.
Score: 0.242
-
Figueiredo-Pereira ME, Serrano PA, Rockwell P. Six promising drug repurposing candidates for Alzheimer's disease and their sex-specific mechanisms and efficacy. Neural Regen Res. 2026 Jul 01; 21(7):2882-2888.
Score: 0.236
-
Ndukwe K, Serrano PA, Rockwell P, Xie L, Figueiredo-Pereira ME. Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model. J Alzheimers Dis. 2025 Mar; 104(1):173-190.
Score: 0.228
-
Birnbaum EM, Xie L, Serrano P, Rockwell P, Figueiredo-Pereira ME. BT-11 repurposing potential for Alzheimer's disease and insights into its mode of actions. bioRxiv. 2024 Oct 29.
Score: 0.223
-
Wallace CH, Oliveros G, Xie L, Serrano P, Rockwell P, Figueiredo-Pereira M. Potential Alzheimer's early biomarkers in a transgenic rat model and benefits of diazoxide/dibenzoylmethane co-treatment on spatial memory and AD-pathology. Sci Rep. 2024 02 14; 14(1):3730.
Score: 0.213
-
Ndukwe K, Serrano PA, Rockwell P, Xie L, Figueiredo-Pereira M. Histone deacetylase inhibitor RG2833 has therapeutic potential for Alzheimer's disease in females. bioRxiv. 2023 Dec 29.
Score: 0.211
-
Oliveros G, Wallace CH, Chaudry O, Liu Q, Qiu Y, Xie L, Rockwell P, Figueiredo-Pereira ME, Serrano PA. Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. Brain. 2023 03 01; 146(3):898-911.
Score: 0.199
-
Wallace CH, Oliveros G, Serrano PA, Rockwell P, Xie L, Figueiredo-Pereira M. Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer's model. Life Sci Alliance. 2022 09 27; 5(12).
Score: 0.193
-
Avila JA, Kiprowska M, Jean-Louis T, Rockwell P, Figueiredo-Pereira ME, Serrano PA. PACAP27 mitigates an age-dependent hippocampal vulnerability to PGJ2-induced spatial learning deficits and neuroinflammation in mice. Brain Behav. 2020 01; 10(1):e01465.
Score: 0.159
-
Corwin C, Nikolopoulou A, Pan AL, Nunez-Santos M, Vallabhajosula S, Serrano P, Babich J, Figueiredo-Pereira ME. Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets. J Neuroinflammation. 2018 Sep 20; 15(1):272.
Score: 0.146
-
Avila JA, Zanca RM, Shor D, Paleologos N, Alliger AA, Figueiredo-Pereira ME, Serrano PA. Chronic voluntary oral methamphetamine induces deficits in spatial learning and hippocampal protein kinase Mzeta with enhanced astrogliosis and cyclooxygenase-2 levels. Heliyon. 2018 Feb; 4(2):e00509.
Score: 0.140
-
Chaudry O, Ndukwe K, Xie L, Figueiredo-Pereira M, Serrano P, Rockwell P. Females exhibit higher GluA2 levels and outperform males in active place avoidance despite increased amyloid plaques in TgF344-Alzheimer's rats. Sci Rep. 2022 11 09; 12(1):19129.
Score: 0.049